Početna › Multipla skleroza › Maryland
Kliničke studije za Multipla skleroza u državi Maryland
17 studija za Multipla skleroza traži sudionike na lokacijama u državi Maryland.
Gradovi u državi Maryland
Službeni tekst studije (engleski)
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 1/2
Od 18 do 120 godina · Oba spola · Ažurirano 2. lis 2026. · NCT03109288Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
1 Month – 99 Years · Oba spola · Ažurirano 2. lis 2026. · NCT00794352Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Baltimore
- TG Therapeutics Investigational Trial Site, Glen Burnie
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06433752Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 2
Od 18 do 120 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT02784210Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 120 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT00001248RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Sunstone Therapies, PC, Rockville
- Sheppard Pratt, Towson
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Baltimore Veterans Affairs Medical Center- Site Number : 8400163, Baltimore
U tijeku regrutacijaFaza 3
Od 18 do 60 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07325292Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 2 do 120 godina · Oba spola · Ažurirano 31. kol 2026. · NCT01730131A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Mid Atlantic Epilepsy and Sleep Ctr, Bethesda
U tijeku regrutacijaFaza 3
Od 18 do 65 godina · Oba spola · Ažurirano 29. srp 2026. · NCT07225504Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- Johns Hopkins University, Baltimore
U tijeku regrutacijaFaza 2
Od 18 do 60 godina · Oba spola · Ažurirano 17. srp 2026. · NCT07497399Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
- Johns Hopkins University, Baltimore
U tijeku regrutacijaFaza 2
Od 18 do 60 godina · Oba spola · Ažurirano 9. lip 2026. · NCT06170970Pathological Basis of MRI Signal Changes in Multiple Sclerosis
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 120 godina · Oba spola · Ažurirano 5. lip 2026. · NCT02659956Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 1
Od 18 do 120 godina · Oba spola · Ažurirano 5. lip 2026. · NCT05849467Genes and Environment in Multiple Sclerosis
- National Institute of Neurological Disorders and Stroke, Bethesda
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 14. svi 2026. · NCT01353547Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
- Johns Hopkins University, Baltimore
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 6. svi 2026. · NCT07389590A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- Evidera INC., Bethesda
- Evidera, Bethesda
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Žene · Ažurirano 20. stu 2025. · NCT05170126Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.